The National Center for Health Statistics reports that the percentage of Americans aged 65+ with obesity has doubled to 40% for both men and women. While pharmacotherapies like GLP-1 receptor agonists ...
Muscle cars are supposed to be relics, museum pieces from a gasoline-soaked past. Yet when I follow the money, the ...
We all know that strength training is essential for toning up, boosting our metabolism, and increasing bone density to reduce ...
IF YOUR MAIN FITNESS goal is to add mass and chisel out your figure, then the thought of building "lean muscle" likely sounds rather appealing. After all, why would you dedicate hours in the gym and ...
Weight loss drugs have soared in popularity in the past year, helping some lose dramatic amounts of weight — but not all that weight is fat. Some of that is actually lean mass, which is everything in ...
Laura Schober is a writer and editor specializing in health, food, wellness, beauty, and lifestyle content. Laura is also a seasoned communications professional who has previously worked in the ...
Altimmune, Inc. shares surged nearly 30% after positive Phase 2 clinical study results for pemvidutide, a GLP-1/glucagon dual receptor agonist for obesity and MASH. Pemvidutide may compete with Novo ...
IRVINE, Calif., October 31, 2025--(BUSINESS WIRE)--Immunis, Inc., a clinical-stage biotech developing innovative stem cell-derived biologics for age- and disease-related immune dysregulation, ...